Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from the IPO price. The sharp rally comes as the newly listed company reported a strong Q1 FY27 performance, swinging to a profit of Rs 58.75 crore from a loss in the year-ago quarter.
Market Samachar is a news aggregator. This article was originally published by Stocks-Markets-Economic Times. Tap the button above to read the full story on their site.